Search

Search Results
Results 4451 - 4460 of 4807 for Movement Disorder
  • Multiple Sclerosis and the Epstein Barr Virus
    Health - 26 Feb 2019
    Epstein-Barr virus (EBV) is a herpes virus otherwise known of as human herpesvirus 4 (HHV-4). It is most well known for causing glandular fever but research shows that EBV infection is also linked to...
  • Ceftriaxone Viatris
    Drug - 31 Mar 2025
    Consumer Medicine Information (CMI) about Ceftriaxone Viatris intended for persons living in Australia.
  • The Future of Hospital Care with Smart Bed Technology
    Health - 12 Mar 2025
    Smart beds integrate IoT and AI technologies, offering real-time monitoring of patients' vital signs and enhancing safety and comfort in healthcare settings.
  • Solu-Medrol
    Drug - 12 Mar 2025
    Consumer Medicine Information (CMI) about Solu-Medrol intended for persons living in Australia.
  • Olumiant
    Drug - 6 Mar 2025
    Consumer Medicine Information (CMI) about Olumiant intended for persons living in Australia.
  • Flagyl
    Drug - 4 Mar 2025
    Consumer Medicine Information (CMI) about Flagyl intended for persons living in Australia.
  • Flagyl S
    Drug - 4 Mar 2025
    Consumer Medicine Information (CMI) about Flagyl S intended for persons living in Australia.
  • Tamate
    Drug - 19 Feb 2025
    Consumer Medicine Information (CMI) about Tamate intended for persons living in Australia.
  • Combivir
    Drug - 13 Feb 2025
    Consumer Medicine Information (CMI) about Combivir intended for persons living in Australia.
  • Cardizem CD and Cardizem
    Drug - 13 Feb 2025
    Consumer Medicine Information (CMI) about Cardizem CD and Cardizem intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback